MyFinsight
Home
Blog
About
Contact
Download
Download image
Redemptions of marketable
securities
$4,250,000
Net cash flows
provided by investing...
$4,250,000
Effect of foreign
exchange rates on cash
$17,585
Change in cash and cash
equivalents for the period
$494,958
Canceled cashflow
$3,772,627
Stock-based compensation
$262,915
Unrealized loss (gain) on
equity securities
-$59,451
Vesting of restricted
common stock issued for...
$38,800
Write-off of deferred
offering costs
$33,604
Non-cash lease
adjustments
$18,727
Other assets
-$10,648
Depreciation and
amortization
$3,853
Net cash flows used
in operating...
-$3,772,627
Canceled cashflow
$427,998
Net loss
-$3,329,171
Accounts payable and
accrued expenses
-$705,025
Foreign currency
remeasurement gain
$77,286
Prepaid expenses and
other current assets
$49,508
Accretion of discounts on
available for sale debt...
$20,172
Operating lease
liabilities
-$19,463
Back
Back
Cash Flow
Lantern Pharma Inc. (LTRN)
Lantern Pharma Inc. (LTRN)
source: myfinsight.com